FPIs favour consumption and healthcare, testing India’s growth story

By: Team India Tracker

FPIs invested ₹20,202 crore in Indian equities in July, ending a four-month selling streak. After pulling out about ₹2.6 lakh crore in the previous four months, the reversal is striking

Foreign investors are buying Indian stocks again. The more important question is what they are refusing to buy. 

Foreign portfolio investors (FPIs) poured Rs 20,202 crore into Indian equities in July, ending a four-month selling streak. In the second half alone, they bought Rs 4,642 crore. After withdrawing roughly Rs 2.6 lakh crore in the preceding four months, the reversal looks striking. 

But the sectoral pattern suggests something less dramatic than a wholesale return of confidence. Foreign money is rotating within India, not simply rushing back into it. 

Consumer durables led buying in the second half of July, attracting Rs 4,958 crore. Healthcare drew Rs 3,654 crore and information technology Rs 3,298 crore. Consumer services received Rs 2,840 crore, while automobiles and auto components attracted Rs 2,372 crore. 

At the other end, capital goods suffered the biggest outflow, at Rs 3,618 crore. Telecommunications lost Rs 3,271 crore and financial services Rs 2,669 crore. Power and construction saw outflows of Rs 1,596 crore and Rs 1,602 crore, respectively. 

That divergence says more than the headline inflow. 

Investors appear to be moving towards sectors where they can still find reasonable valuations or a fresh earnings story, while trimming positions that have already benefited from India’s investment and infrastructure narrative. 

Consumer durables are the clearest expression of a bet on India’s next growth phase. There are signs that demand for everyday consumer goods is improving, raising hopes that stronger household incomes and confidence will eventually translate into spending on refrigerators, televisions, appliances and other discretionary products. 

That would be economically significant. Consumption becomes a more powerful growth engine when households move beyond necessities. But the story still needs proving. Improving FMCG demand is not yet evidence of a broad-based discretionary consumption boom. The real test is whether consumers begin making larger purchases consistently. 

Healthcare offers a less cyclical proposition. India remains short of hospital capacity, while rising incomes and health awareness are expanding demand for medical services. Strong earnings among listed hospital companies also offer investors a structural growth story backed by visible corporate performance. 

IT has a different attraction. After a prolonged correction, Indian technology stocks have become more appealing on valuation. With the global technology trade increasingly concentrated around artificial intelligence, some investors may be trimming expensive technology names without abandoning the sector. Indian IT companies offer exposure to technology at valuations that, in some cases, look less demanding. 

The selling in capital goods is therefore revealing. India’s infrastructure and investment story remains intact. But investors do not buy economic narratives; they buy earnings at a price. After a strong rally, capital-goods stocks may simply have become too expensive relative to the profits expected from them. Taking money off the table can signal discipline rather than pessimism. 

The same applies to financial services, power and construction. Foreign investors may still believe in India’s long-term growth story while deciding that some popular beneficiaries have already captured too much of that growth in their share prices. 

The return of foreign money also reflects a changing global risk equation. 

The preceding four months were marked by the US-Iran conflict, higher oil prices and fears of a wider energy shock. India is particularly vulnerable to crude because it imports most of its oil. Higher prices simultaneously hit the trade balance, inflation and the rupee. 

If oil prices remain contained or fall, the benefits would extend beyond petrol prices. India’s import bill would shrink, external pressures would ease and inflation could become less troublesome, improving the backdrop for domestic demand and foreign investment. 

India also retains an advantage in relative valuations. The stock market has not delivered spectacular gains over the past two years even as corporate earnings have expanded. That creates pockets where prices have not risen as quickly as profits. For global investors seeking alternatives to expensive US technology stocks, that may be enough to reopen the India trade. 

Still, July’s inflows are no clean bill of health. Indian equities remain expensive in several segments. Global interest rates can quickly redirect capital. A surge in crude prices could reverse recent optimism, while geopolitical shocks and currency movements remain beyond India’s control. 

More importantly, foreign investors will eventually demand evidence that earnings justify the prices they are paying. 

So July’s message is less that foreign investors are simply returning to India and more that they are changing what they want from it. 

They want consumption before it becomes crowded, healthcare with structural demand, technology at reasonable valuations and companies whose earnings can catch up with their share prices. 

That is an uncomfortable but useful message for India. Foreign capital will not finance every part of the growth story simply because the economy is expanding. The market is becoming more discriminating. 

India is no longer being bought as one trade. It is being priced sector by sector, earnings story by earnings story.